Europe

MK-3655 is a monoclonal antibody agonist of the b-Klotho/FGFR1c receptor complex. The drug is being studied to treat nonalcoholic steatohepatitis (NASH) and type 2 diabetes.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Acer Therapeutics, headquartered in Newton, Mass., in-licensed osanetant, a clinical-stage, selective, non-peptide tachykinin NK3 receptor antagonist from Paris-based Sanofi.
Polarean Imaging plc is pleased to announce that all the Resolutions set out in the circular dated 11 December 2018 (the “Circular”), including those necessary to implement the Fundraise to raise a total of US$4 million (£3.125 million) (before expenses), were duly passed at the General Meeting of the Company held in London earlier today.
Immunicum AB has, as previously announced, implemented a directed issue to a number of institutional and private investors. The newly implemented share issue has entailed a change in number of shares and votes in the Company.
Medtronic plc today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco.
PwC recently came out with the latest version of their annual R&D spending report, and while there is a lot of interesting information to digest in this report, there are a few companies in particular that stand out within the field of biotechnology.
Researchers with the Francis Crick Institute and the Institute of Cancer Research recently published research suggesting that a new class of drugs that is helpful in treating breast cancers could help treat some of the hardest-to-treat lung cancers.
FDA
The vaccine, Vaxelis, was approved to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenza type b.
The battle of the bulge is ongoing and it appears that Americans are losing, according to a report from the U.S. Centers for Disease Control and Prevention. The report shows that Americans are losing height and gaining girth.
PRESS RELEASES